Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial
Summary The efficacy of romosozumab (ROMO) in treating glucocorticoid-induced osteoporosis remains unclear. This randomized clinical trial demonstrated that in patients initiating glucocorticoid therapy, a treatment regimen of 12 months of ROMO followed by 24 months of…